==== Front
J Clin Invest
J Clin Invest
J Clin Invest
The Journal of Clinical Investigation
0021-9738
1558-8238
American Society for Clinical Investigation

173145
10.1172/JCI173145
Corrigendum
Mesenchymal cell replacement corrects thymic hypoplasia in murine models of 22q11.2 deletion syndrome
Bhalla Pratibha
Du Qiumei
Kumar Ashwani
Xing Chao
Moses Angela
Dozmorov Igor
Wysocki Christian A.
Cleaver Ondine B.
Pirolli Timothy J.
Markert Mary Louise
de la Morena Maria Teresa
Baldini Antonio
van Oers Nicolai S.C.
3 7 2023
3 7 2023
3 7 2023
133 13 e173145© 2023 Bhalla et al.
2023
Bhalla et al.
https://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
This article is available online at https://www.jci.org/articles/view/173145
==== Body
pmcOriginal citation: J Clin Invest. 2022;132(22):e160101. https://doi.org/10.1172/JCI160101

Citation for this corrigendum: J Clin Invest. 2023;133(13):e173145. https://doi.org/10.1172/JCI173145

In the original version of Figure 5A, the images for Tbx1neo2/neo2 and Foxn11089/1089 hypoplastic lobes were duplicates. The correct figure part is below. The HTML and PDF files have been updated online.

The authors regret the error.

Version 1 07/03/2023

Electronic publication

See the related article at Mesenchymal cell replacement corrects thymus hypoplasia in murine models of 22q11.2 deletion syndrome.